Answers are grounded in this paper and cite their sources.
The tetranuclear Lu and Y polyhydrido complexes [(C5Me4SiMe3)Ln(mu-H)2]4(THF) (Ln = Lu, Y) undergo novel multiple hydrogenation reactions with unsaturated organic compounds such as benzonitrile, gamma-butyrolactone, styrene, and 1,4-bis(trimethylsilyl)-1,3-butadiyne to afford a series of structurally characterizable polynuclear complexes that possess novel structures and are otherwise difficult to access. Most of these reactions are unprecedented and can be attributed to the unique cooperative effects of multiple active sites in the polyhydrido rare earth metal complexes.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: